CNS Pharmaceuticals, Inc.
CNSP
$5.78
-$0.16-2.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.59M | -4.94M | -5.96M | -3.22M | -2.37M |
| Total Depreciation and Amortization | 11.10K | 1.90K | 1.00K | 700.00 | 900.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.40K | 2.60K | 87.60K | 18.50K | 21.60K |
| Change in Net Operating Assets | -965.00K | 284.00K | 2.82M | 1.03M | -2.99M |
| Cash from Operations | -3.54M | -4.65M | -3.05M | -2.17M | -5.34M |
| Capital Expenditure | -3.80K | -6.20K | -18.20K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.80K | -6.20K | -18.20K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -90.80K | -96.20K | -30.80K | -91.00K | -89.10K |
| Issuance of Common Stock | 20.71M | 500.90K | 501.70K | 800.00 | 4.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -46.00K | -- | -64.10K | -1.50K | 0.00 |
| Cash from Financing | 20.58M | 404.70K | 406.90K | -91.60K | 4.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.03M | -4.25M | -2.66M | -2.27M | -918.20K |